Who makes Nicotine Replacement Therapy (NRT)?

Nicotine Replacement Therapy (NRT) is developed by Pfizer Inc..

What development phase is Nicotine Replacement Therapy (NRT) in?

Nicotine Replacement Therapy (NRT) is FDA-approved (marketed).

What is the generic name of Nicotine Replacement Therapy (NRT)?

nicotine-replacement-therapy-nrt is the generic (nonproprietary) name of Nicotine Replacement Therapy (NRT).

Last reviewed 2026-05-15 · How we verify

Nicotine Replacement Therapy (NRT) (nicotine-replacement-therapy-nrt)

Pfizer Inc. · FDA-approved active Quality 2/100

At a glance

Generic name	nicotine-replacement-therapy-nrt
Sponsor	Pfizer Inc.
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Metabolome and Gut Microbiome Changes During Smoking Cessation in Long-term Drug Therapy in a Therapeutic Community (NA)
A Study Of Vagal Nerve Stimulation In Conjunction With NRT For Smoking Cessation (PHASE2,PHASE3)
Smoking Cessation and Menstrual Cycle Phase (PHASE4)
Cytisine vs Nicotine Replacement Therapy (NA)
ACT Lung Health Intervention: Phase Two (NA)
iCanQuit Smoking Cessation Among Hispanic Adults (PHASE3)
Varenicline for Smoking Reduction in Veterans Not Ready To Quit (PHASE4)
Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Nicotine Replacement Therapy (NRT) CI brief — competitive landscape report
Nicotine Replacement Therapy (NRT) updates RSS · CI watch RSS
Pfizer Inc. portfolio CI